FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $42,527,968 | -83.7% | 4,214,863 | -63.8% | 0.37% | -79.7% |
| Q3 2022 | $261,207,000 | -1.4% | 11,655,833 | +1.6% | 1.82% | +16.2% |
| Q2 2022 | $265,041,000 | -37.8% | 11,473,655 | +4.4% | 1.57% | -11.9% |
| Q1 2022 | $426,012,000 | -29.4% | 10,988,182 | +6.6% | 1.78% | -2.5% |
| Q4 2021 | $603,365,000 | -6.6% | 10,312,167 | -5.4% | 1.82% | +17.5% |
| Q3 2021 | $646,177,000 | -0.5% | 10,902,258 | +45.7% | 1.55% | +28.4% |
| Q2 2021 | $649,458,000 | +20.2% | 7,483,102 | +14.2% | 1.21% | +12.7% |
| Q1 2021 | $540,422,000 | +104.8% | 6,554,546 | +125.9% | 1.07% | +52.8% |
| Q4 2020 | $263,852,000 | +358.4% | 2,901,700 | +101.5% | 0.70% | +105.9% |
| Q3 2020 | $57,556,000 | +64.5% | 1,439,970 | +41.2% | 0.34% | -9.3% |
| Q2 2020 | $34,990,000 | +183.8% | 1,019,830 | +83.7% | 0.38% | +22.5% |
| Q1 2020 | $12,328,000 | +46.1% | 555,082 | +28.8% | 0.31% | +44.1% |
| Q4 2019 | $8,437,000 | +60.2% | 431,128 | +27.2% | 0.21% | +85.2% |
| Q3 2019 | $5,265,000 | +16.8% | 339,039 | +52.7% | 0.12% | +0.9% |
| Q2 2019 | $4,508,000 | – | 222,064 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |